Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 231 to 240 of 302

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)TA334
Bladder cancer: diagnosis and managementNG2
The Oncentra Prostate v4.x for ultrasound‑guided real‑time HDR brachytherapy in men with localised prostate cancerMIB16
Erythropoiesis‑stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapyTA323
Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimenTA316
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancerTA310
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapyTA307
Cancer services for children and young peopleQS55
Ovarian cancer (advanced): bevacizumab 7.5 mg/kg in combination with paclitaxel and carboplatin for first-line treatmentESUOM21
EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancerDG9

Results per page

  1. 10
  2. 25
  3. 50
  4. All